News
Dexamethasone helps cancer patients with non-immunogenic tumours survive longer after surgery
Patients with non-immunogenic cancers, such as breast and gynaecological cancers, who are given the anti-nausea drug dexamethasone during surgery survive longer. The study, abstract 4224, presented at the Anesthesiology 2021 annual meeting, held October 8 to 12, San Diego, found…
What’s new in supportive care? presentations from ESMO 2021
Supportive care studies presented at ESMO Congress 2021 highlight the urgent need for survivors to get more support to tackle long-term symptoms and for doctors and patients to get up to date information in a fast-changing oncology landscape. The need…
Round-up of prostate and breast cancer studies from ESMO 2021
The 2021 Congress of the European Society for Medical Oncology (ESMO), held 16‒21 September, featured studies that are likely to impact a broad spectrum of clinical practice. We summarise some of the findings that could change treatments for two of…
Guiding principles for developing European comprehensive cancer networks proposed
The European Cancer Organisation and Organisation of European Cancer Institutes have put forward key principles to guide the development of a European Network of Comprehensive Cancer Centres. In a position paper published on September 8th, they set out seven recommendations they…
Cancer World Editor heads new AACR cancer prevention working group
Adriana Albini, Editor in Chief of Cancer World, has been appointed Chair of the new Cancer Prevention Working Group (CPWG) of the American Association for Cancer Research (AACR). “I’m so happy and honoured to have this responsibility, and with the…
Low risk prostate cancer: real-world data reveals high rates of switching from surveillance to treatment
Over half of men initially managed with active surveillance (AS) for ‘low risk’ prostate cancer switch within four years to definitive treatments (e.g., surgery or radiation therapy). The Canadian study, published in Urology, (20 August) provides real-world data on uptake…
Careers of women in oncology hit by Covid-19 pandemic
The pandemic has seen the careers of female physicians working in oncology suffer as they have taken on more domestic responsibilities during lockdowns. Recent studies have indicated the trend may be global and long lasting. A new paper published in…
Blood pressure drugs improve survival in colorectal cancer
Common Blood pressure drugs may improve survival in colorectal cancer (CRC). The study, published in Cancer Medicine, (August issue), showed use of Angiotensin Converting Enzyme (ACE) inhibitors, beta blockers and thiazide diuretics were all associated with decreased cancer specific mortality.…
Cancer community fights back against Covid-19 related delays
The European Cancer Organisation is making materials available to download in 30 different languages to help advocates across Europe lobby national governments to tackle the Covid-19 threat to cancer services in their own countries. The European Time to Act campaign,…
The right to health in Latin America: feeling worthy of cancer treatment
Inequalities influence not only access to cancer care but also patients’ perceptions of their right to choose between treatment options and their expectations of receiving quality care. Researchers evaluating how countries in the Americas design their cancer control policies have…